Building Maven Clinic when No One Believed with CEO Kate Ryder
In this episode of Lifers, CEO Kate Ryder discusses the evolution of Maven Clinic, the first unicorn in women's health, focusing on the challenges of scaling from $200M to $500M in revenue and aligning every part of the business. She shares insights on the distinct hurdles at each growth stage—zero to one, $1‑$10 M, $10‑$100 M—and emphasizes the importance of hiring for the company’s current stage, building a resilient team, and using storytelling to convey the patient‑centered mission. Ryder also reflects on her background as a writer and how narrative drives both investor interest and patient engagement in healthcare.
Dr. Oliver Kharraz on the Decades-Long Journey to Make Scheduling a Doctor's Appointment Easier
In this episode, Christina Farr talks with Oliver Kharraz, CEO of Zocdoc, about the 15‑year quest to simplify doctor appointment scheduling. Kharraz explains how hidden appointment inventory and last‑minute cancellations can be leveraged as a matchmaking clearinghouse, and recounts early...
[Emergency Pod] Peptides - Part 1 with Sunita Mohanty of Ultralight
In this episode of Lifers, host Christina Farr talks with Sunita Mohanty, CEO and co‑founder of Ultralight, about the booming interest in peptide therapies for wellness and longevity. Sunita explains that while peptides are gaining popularity—driven by anecdotal success, recent...
Is Healthcare Safe From the SaaS Bloodbath? With Omada CEO Sean Duffy and Stephanie Davis
In this episode of Lifers, host Christina Farr talks with Omada Health CEO Sean Duffy and equities analyst Stephanie Davis about whether the current SaaS market downturn, driven by AI hype and tightening valuations, threatens digital health firms. Duffy explains...
President of Microsoft Science Saw ChatGPT Coming (and Now He Predicts How It Will Change Healthcare) | Peter Lee
In this episode, Peter Lee, President of Microsoft Research, recounts the evolution of AI from early neural networks to today’s large language models, describing how Microsoft recognized OpenAI’s potential early on and invested heavily despite industry skepticism. He explains the...
Othman Laraki, Color CEO, on Surviving Three Major Pivots
In this episode, Othman Laraki, CEO of Color, recounts the company’s three major pivots—from a cancer genetics startup to its current health‑tech platform—highlighting the financial, team, and market challenges each transition entailed. He stresses that while technology and product are...